# AusperBio Therapeutics raises $120M Series C led by Harbert Growth Partners

> AusperBio Therapeutics, based in United States, has raised $120M in a Series C led by Harbert Growth Partners, announced on 27 August 2026.

Source: https://millionrounds.com/news/rounds/ausperbio-therapeutics-series-c-2026-08 (Millionrounds; every figure on the page links to its filing or article)

Raised **$120M** 2 sources reported it

Stage **Series C** first round on record

Investors **8** 1 named as lead

Where **US** United States

Biotech Healthcare Pharma

## How big is it?

Against every equity round we recorded in the twelve months to 27 August 2026. Ranks count companies, so the same raise reported twice is counted once.

**#375** equity round of the last twelve months

**#74** Series C of 199 in that time

**#249** round in United States, of 1,111

This round **$120M**

Median Series C **$100M**

1.2 times the median Series C of the last twelve months.

## Who invested

- [**Harbert Growth Partners** 4 rounds in the last twelve months *Led*](https://millionrounds.com/fund/harbert-growth-partners)

Also in the round

- [RA Capital Management](https://millionrounds.com/fund/ra-capital-management)
- [Qiming Venture Partners](https://millionrounds.com/fund/qiming-venture-partners)
- [CDH Investments](https://millionrounds.com/fund/cdh-investments)
- [BioVenture](https://millionrounds.com/fund/yuanbio-venture-capital)
- [Sherpa Capital](https://millionrounds.com/fund/sherpa-capital)
- [Hankang Capital](https://millionrounds.com/fund/hankang-capital)
- [InnoPinnacle Fund](https://millionrounds.com/fund/innopinnacle-fund)

## Funding history

- August 2026 Series C **$120M**

This is the first round we hold for the company.

## Reported by

- TechStartups 28 August
- Ventureburn 28 August

The round's figures come from these reports; each link opens the original.

## Other big rounds that week

[**Instinct** $250M Series B](https://millionrounds.com/news/rounds/instinct-series-b-2026-08)[**Owner** $240M Series D](https://millionrounds.com/news/rounds/owner-series-d-2026-08)[**Generalist** $200M Series B](https://millionrounds.com/news/rounds/generalist-series-b-2026-08)[**Gatik** $200M Series D](https://millionrounds.com/news/rounds/gatik-series-d-2026-08)[**Emerald AI** $150M Series A](https://millionrounds.com/news/rounds/emerald-ai-series-a-2026-08)[**General Intuition** $220M Growth](https://millionrounds.com/news/rounds/general-intuition-growth-round-2026-08)

[The company **AusperBio Therapeutics on Millionrounds** *→*](https://millionrounds.com/company/ausperbio-therapeutics)[Weekly roundup **Week of 24 August** *→*](https://millionrounds.com/news/weekly/2026-08-24)[Monthly roundup **August 2026** *→*](https://millionrounds.com/news/monthly/2026-08)

**How this article is made**

We write one for every equity round of $100M or more that at least two sources reported. It is put together from our record of rounds, not rewritten from the reports: the ranks and medians count every equity round we read in the twelve months to the round's date. [How we read rounds](https://millionrounds.com/methodology) · [Report a mistake](https://millionrounds.com/corrections)